A new study from Epic Research, a health analytics firm based in Verona, Wisconsin, detected some encouraging news for those who suffer from cystic fibrosis (CF). In 2008, the average life expectancy ...

These drugs helped dramatically improve patients’ quality of life and lung function, resulting in many living years beyond what had been previously expected. Patients with cystic fibrosis now have a ...

Cystic fibrosis (CF) is a rare autosomal recessive disorder that affects numerous systems of the body. It is a complicated disease that differs from person to person. An autosomal recessive disorder ...

So far, based on clinical data, patients with cystic fibrosis (CF) don't appear to be especially susceptible to COVID-19, and when they do get infected, they don't seem to get sicker. But Ruobing ...

BOSTON — With the remarkable advances made in therapy over the past decade, many patients with cystic fibrosis (CF) can expect to survive into their 50s and even well beyond. But as patients with CF ...

Care for patients with cystic fibrosis has undergone transformative changes over the past decade and serves as an example of how an understanding of the functional consequences of a genetic disease ...

There are many new drugs to treat cystic fibrosis, but non-white patients are far less likely to receive the latest precision medicines, accord to a new study. These drugs were approved by the U.S.

Patients with cystic fibrosis (CF) who did not receive a lung transplant developed cardiovascular disease, kidney problems, and cancer at higher rates than those without CF. Those with CF who did ...

BUFFALO, N.Y. – During the 1950s, a child with cystic fibrosis rarely lived long enough to attend elementary school. Today, many people with CF are achieving their dreams of pursuing careers, getting ...

Arcturus Therapeutics (ARCT) is continuing to evaluate the use of LUNAR-CF [ARCT-032] for the treatment of patients with Cystic Fibrosis [CF]. The promising thing about this program is that the ...

Vertex Pharmaceuticals Incorporated (VRTX) is a good long-term pharmaceutical company to look into. That's because it is already performing well in the Cystic ...